Documente Academic
Documente Profesional
Documente Cultură
(Espay, 2014)
Arginine Vasopressin
Principle sites of action: the kidney and blood
vessels.
AVP acts on renal collecting ducts via
V2 receptors to increase water permeability
decreased urine output increases blood
volume, cardiac output and arterial pressure.
AVP binds to V1 receptors on vascular smooth
muscle to cause vasoconstriction
http://www.cvphysiology.com/Blood%20Pressure/BP016
280 mosm 280 mosm
ICF ECF
Sel H2O
Sel H2O
HYPONATREMIA
(Espay, 2014)
seizures in patients with hyponatremia medical emergency that should
be managed with rapid but partial correction of the serum sodium.
DIAGNOSTIC
HYPONATREMIA
ALGORITM DIAGNOSIS OF
EXCLUDE HYERGLYCEMIA AND OTHER CAUSES
OF NON-HYPOTONIC HYPONATREMIA
HYPONATRAEMIA
HYPOTONIC HYPONATREMIA
ACUTE OR
SEVERE YES
SYMPTOMS?
Consider immediate
treatment with hypertonic
saline
NO
URINE OSMOLALITY
URINE OSMOLALITY
ALGORITM DIAGNOSIS OF
HYPONATRAEMIA 100 mOsm/kg > 100 mOsm/kg
Consider
Primary polydipsia URINE SODIUM
Low solute intake
Beer potamania
LOW EFFECTIVE
DIURETICS
ARTERIAL VOLUME
OR
KIDNEY
HYPERVOLEMIA DISEASE NO
Heart failure
YES
Liver failure
Nephrotic syndrome
HYPOVOLEMIA NORMOVOLEMIA
HYPOVOLEMIA Vomiting SIADH
Diarrhea,vomiting Addison y ACTH deficiency
Third spacing Renal salt wasting Hypothyroidism
Remote diuretics Cerebral salt wasting Occult diuretics
Occult diuretics
HYPOVOLEMIC HYPONATREMIA
EXTRARENAL LOSSES
Gastrointestinal (emesis, diarrhea)
Skin (sweating or burns)
Third space losses (bowel obstruction, peritonitis, sepsis)
RENAL LOSSES
Thiazide or loop diuretics
Osmotic diuresis
Postobstructive diuresis
Polyuric phase of acute tubular necrosis
Juvenile nephronophthisis (OMIM 256100/606966/602088/604387/611498)
Autosomal recessive polycystic kidney disease (OMIM 263200)
Tubulointerstitial nephritis
Obstructive uropathy
Cerebral salt wasting
Proximal (type II) renal tubular acidosis (OMIM 604278) *
Lack of aldosterone effect (high serum potassium):
Absence of aldosterone (e.g., 21-hydroxylase deficiency [OMIM 201910])
Pseudohypoaldosteronism type I (OMIM 264350/177735)
Urinary tract obstruction and/or infection
EUVOLEMIC HYPONATREMIA
Syndrome of inappropriate antidiuretic hormone secretion
Nephrogenic syndrome of inappropriate antidiuresis (OMIM 304800)
Desmopressin acetate
Glucocorticoid deficiency
Hypothyroidism
Water intoxication:
Iatrogenic (excess hypotonic intravenous fluids)
Feeding infants excessive water products
Swimming lessons
Tap water enema
Child abuse
Psychogenic polydipsia
Diluted formula
Beer potomania
Exercise-induced hyponatremia
HYPERVOLEMIC HYPONATREMIA
Heart failure
Cirrhosis
Nephrotic syndrome
Acute, chronic kidney injury
Capillary leak caused by sepsis
Hypoalbuminemia caused by gastrointestinal disease (protein-losing
enteropathy)
Differentiating CSW & SIADH
CSW SIADH Diabetes Insipidus
Plasma Volume
Salt Balance Negative Variable
Dehydration Present Absent Present
Weight / no change
Pulmonary Capillary Wedge / no change
Pressure
Central Venous Pressure / no change
Hematocrit / Normal
Serum Osmolality / Normal
BUN/Creatinine Ratio Normal
Urine Sodium Concentration Significantly Normal
Serum Uric Acid Concentration / Normal
Urine Output
Serum Albumin Concentration Normal
Urin
Pemeriksaan UNa : berguna untuk evaluasi
hiponatremia dan GGA
Hypovolemic hyponatremia: tubulus renalis
reabsorpsi natrium sebanyak mungkin
UNa < 20 mEq/L.
SIADH: euvolemic hyponatremia ekskresi
natrium urin normal UNa > 40 mEq/L
Bartter and Schwartz criteria for SIADH
Decreased plasma osmolality (<275 mosm/kg)
Inappropriately concentrated urine (>100
mosm/kg) for hyponatremia
Euvolemic
Elevated urine Na (>20 mEq/L)
Exclude hipothyroidism, hypocortisolism and
diuretic use.
Drugs commonly associated with development
of SIADH
MANAGEMENT
Principles of treatment in
hyponatremia
The most common and devastating effects of
hyponatremia are of CNS origin. Therefore, identifying
the risk factors that lead to hyponatremia and
instituting prompt treatment while avoiding
complications is crucial.
Although cerebral adaptation to low serum Na occurs
slowly, it protects the brain from deleterious effects of
hypo-osmolality. However, this protective mechanism
leaves the brain susceptible to osmotic demyelination
syndrome (ODS) during treatment, especially in
persons with chronic hyponatremia, if the correction is
rapid.
http://emedicine.medscape.com/article/907841-treatment
Effects of hyponatremia on the brain
and adaptive mechanism
Management of hypovolemic
hyponatremia
Immediate goal : correct volume depletion with
normal saline.
Hemodynamically stable: correct hyponatremia
No consensus of optimal treatment of symptomatic
hyponatremia.
Relatively small increase in the serum Na
concentration (5%) substantially reduce cerebral
edema.
Recommended rate of correction 8-12 mEq/L/day.
In patients with seizure, 3% NaCl should be given
while volume depletion is being corrected.
http://emedicine.medscape.com/article/907841-treatment
Management of normovolemic
hyponatremia
Syndrome of inappropriate antidiuretic hormone
secretion (SIADH)
fluid restriction (administration of normal saline)
Neurological emergency
3% NaCl + furosemide IV: raise serum Na until
symptoms resolve symptoms typically resolve with
rise in sodium of 3-7 mEq/L.
Dose of 3% NaCl : 1-2 mL/Kg
correction does not exceed 8 mEq/L/d
Furosemide: balance volume expansion by 3% Na
infusion
Dose 1-2 mg/kg
http://emedicine.medscape.com/article/907841-treatment
Equations used in managing
hyponatremia
To estimate the effect of 1 L of any Na concentrations of various fluids
infusate on serum Na concentration: used in pediatric practice
Change in Na concentration 3% NaCl in water - 513 mEq/L
= (infusate Na level - serum 0.9% NaCl in water - 154
Na level)/(total body water mEq/L
+ 1) Ringer lactate solution - 130
Change in serum Na level = mEq/L
[(infusate Na level + 0.45% NaCl in water - 77
infusate K level) - serum Na mEq/L
level]/(total body water + 1) 0.2% NaCl in water - 34 mEq/L
5% dextrose in water - 0
mEq/L
http://emedicine.medscape.com/article/907841-treatment
Medicolegal Pitfalls
Failure to consider the possibility of sampling error,
pseudohyponatremia (hyperglycemia,
hyperproteinemia, or hyperlipidemia)
Failure to recognize high-risk groups: patients on
diuretics, infants, postoperative patients, and patients
with malignancy.
Failure to recognize
severe acute hyponatremia ongoing risk of brainstem
herniation must correct it promptly
chronic hyponatremia rapid correction (>0.5 mEq/L/h or
12 mEq/L/d) risk of osmotic demyelination syndrome.